Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
NIHR ARC West, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Br J Surg. 2023 Aug 11;110(9):1171-1179. doi: 10.1093/bjs/znad149.
BACKGROUND: Immediate breast reconstruction after mastectomy can improve the quality of life for women with breast cancer and rates are increasing. Long-term inpatient costs of care were estimated to understand the impact of different immediate breast reconstruction procedures on healthcare expenditure. METHODS: Hospital Episode Statistics Admitted Patient Care data were used to identify women undergoing unilateral mastectomy and immediate breast reconstruction in English National Health Service hospitals (1 April 2009 to 31 March 2015) and any subsequent procedures performed to revise, replace, or complete the breast reconstruction. Costs were assigned to Hospital Episode Statistics Admitted Patient Care data using the Healthcare Resource Group 2020/21 National Costs Grouper. Generalized linear models were used to estimate mean cumulative costs for five immediate breast reconstruction procedures over 3 and 8 years, adjusting for covariates (age/ethnicity/deprivation). RESULTS: A total of 16 890 women underwent mastectomy and immediate breast reconstruction: implant (5192; 30.7 per cent), expander (2826; 16.7 per cent), autologous latissimus dorsi flap (2372; 14.0 per cent), latissimus dorsi flap with expander/implant (3109; 18.4 per cent), and abdominal free-flap reconstruction (3391; 20.1 per cent). The mean (95 per cent c.i.) cumulative cost was lowest for latissimus dorsi flap with expander/implant reconstruction (€20 103 (€19 582 to €20 625)) over 3 years and highest for abdominal free-flap reconstruction (€27 560 (€27 037 to €28 083)). Over 8 years, expander (€29 140 (€27 659 to €30 621)) and latissimus dorsi flap with expander/implant (€29 312 (€27 622 to €31 003)) reconstructions were the least expensive, while abdominal free-flap reconstruction (€34 536 (€32 958 to €36 113)) remained the most expensive, despite having lower costs for revisions and secondary reconstructions. This was driven primarily by the cost of the index procedure (€5435 (expander reconstruction) to €15 106 (abdominal free-flap reconstruction)). CONCLUSION: Hospital Episode Statistics Admitted Patient Care Healthcare Resource Group data provided a comprehensive longitudinal cost assessment of secondary care. Although abdominal free-flap reconstruction was the most expensive option, higher costs of the index procedure need to be balanced against ongoing long-term costs of revisions/secondary reconstructions, which are higher after implant-based procedures.
背景:乳腺癌患者乳房切除术后即刻乳房重建可改善生活质量,且该比例正在增加。为了了解不同即刻乳房重建术式对医疗支出的影响,需要对长期住院护理成本进行估计。
方法:使用英国国家卫生服务(National Health Service,NHS)医院的住院患者医疗数据(2009 年 4 月 1 日至 2015 年 3 月 31 日),识别行单侧乳房切除术和即刻乳房重建的女性,并记录后续任何用于修改、替换或完成乳房重建的手术。使用 2020/21 年 NHS 医疗资源组(Healthcare Resource Group,HRG)对住院患者医疗数据进行成本赋值。使用广义线性模型估计 5 种即刻乳房重建术式在 3 年和 8 年的平均累计成本,调整协变量(年龄/种族/贫困程度)。
结果:共 16890 名女性接受了乳房切除术和即刻乳房重建:植入物(5192 例,30.7%)、扩张器(2826 例,16.7%)、背阔肌皮瓣游离(2372 例,14.0%)、带扩张器/植入物的背阔肌皮瓣(3109 例,18.4%)和游离腹瓣重建(3391 例,20.1%)。3 年内,带扩张器/植入物的背阔肌皮瓣重建的累计成本最低(€20103(€19582 至 €20625)),8 年内,游离腹瓣重建的累计成本最高(€27560(€27037 至 €28083))。8 年内,扩张器(€29140(€27659 至 €30621))和带扩张器/植入物的背阔肌皮瓣(€29312(€27622 至 €31093))重建术的费用最低,而游离腹瓣重建术的费用仍然最高(€34536(€32958 至 €36113)),尽管在修改和二次重建方面的费用较低。这主要是由于索引手术的费用(扩张器重建术€5435 至游离腹瓣重建术€15106)。
结论:住院患者医疗数据的 NHS HRG 提供了对二级护理的全面纵向成本评估。尽管游离腹瓣重建是最昂贵的选择,但需要权衡索引手术更高的费用与植入物相关手术后续修改/二次重建的长期费用,后者的费用更高。
J Egypt Natl Canc Inst. 2006-6
Breast Cancer Res Treat. 2023-1
Plast Reconstr Surg Glob Open. 2019-10-28